blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0812858

EP0812858 - Process for the preparation of a composition containing factor VIII [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  22.05.2015
Database last updated on 11.05.2024
Most recent event   Tooltip10.07.2015Lapse of the patent in a contracting state
New state(s): CH, LI		published on 12.08.2015  [2015/33]
Applicant(s)For all designated states
BIOTEST PHARMA GMBH
Landsteiner Strasse 5
D-63303 Dreieich / DE
[1997/51]
Inventor(s)01 / Bucci, Enzo, Dr.
Via Palmiro Togliatti 25
02010 S. Rufina Cittaducale, Rieti / IT
02 / Kotitschke, Ronald, Dr.
Kleiststrasse 23
63303 Dreieich / DE
03 / Rudnick, Dieter, Dr.
In der Neuen Lach 3
63303 Dreieich / DE
04 / Dichtelmüller, Herbert, Dr.
Rossertstrasse 14
65843 Sulzbach/Ts. / DE
05 / Kloft, Michael, Dr.
Greinstrasse 44
64291 Darmstadt / DE
06 / Loebnau, Wolfgang
Lahnstrasse 7
63533 Mainhausen / DE
07 / Ott, Günter
Ch.-Morgenstern-Strasse 14
63110 Rodgau / DE
[1997/51]
Representative(s)Keller, Günter
Lederer & Keller
Patentanwälte Partnerschaft mbB
Unsöldstrasse 2
80538 München / DE
[N/P]
Former [2003/30]Keller, Günter, Dr.
Lederer & Keller Patentanwälte Prinzregentenstrasse 16
80538 München / DE
Former [1997/51]Müller-Boré & Partner Patentanwälte
Grafinger Strasse 2
81671 München / DE
Application number, filing date97109314.109.06.1997
[1997/51]
Priority number, dateDE1996102329311.06.1996         Original published format: DE 19623293
[1997/51]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP0812858
Date:17.12.1997
Language:DE
[1997/51]
Type: B1 Patent specification 
No.:EP0812858
Date:27.09.2006
Language:DE
[2006/39]
Search report(s)(Supplementary) European search report - dispatched on:EP23.09.1997
ClassificationIPC:C07K14/755
[1997/51]
CPC data not yet available
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1997/51]
TitleGerman:Verfahren zur Herstellung einer Faktor VIII-enthaltenden Zusammensetzung[1997/51]
English:Process for the preparation of a composition containing factor VIII[1997/51]
French:Procédé pour la préparation d'une composition contenant le facteur VIII[1997/51]
Examination procedure12.06.1998Examination requested  [1998/33]
10.10.2003Despatch of a communication from the examining division (Time limit: M06)
20.04.2004Reply to a communication from the examining division
14.06.2004Despatch of a communication from the examining division (Time limit: M04)
22.10.2004Reply to a communication from the examining division
16.03.2006Date of oral proceedings
05.04.2006Minutes of oral proceedings despatched
25.04.2006Communication of intention to grant the patent
07.08.2006Fee for grant paid
07.08.2006Fee for publishing/printing paid
Opposition(s)Opponent(s)01  27.06.2007    ADMISSIBLE
Baxter Aktiengesellschaft
Industriestrasse 67
1221 Wien / AT
Opponent's representative
Alge, Daniel, et al, et al
SONN Patentanwälte OG
Riemergasse 14
1010 Wien / AT
 [N/P]
Former [2007/31]
Opponent(s)01  27.06.2007    ADMISSIBLE
Baxter Aktiengesellschaft
Industriestrasse 67
1221 Wien / AT
Opponent's representative
Alge, Daniel, et al, et al
Sonn & Partner Patentanwälte Riemergasse 14
1010 Wien / AT
06.08.2007Invitation to proprietor to file observations on the notice of opposition
11.04.2008Reply of patent proprietor to notice(s) of opposition
10.02.2010Date of oral proceedings
26.03.2010Despatch of minutes of oral proceedings
26.03.2010Despatch of communication that the patent will be revoked
20.11.2014Legal effect of revocation of patent [2015/26]
Appeal following opposition17.05.2010Appeal received No.  T1170/10
05.08.2010Statement of grounds filed
20.11.2014Result of appeal procedure: appeal of the proprietor was rejected
20.11.2014Date of oral proceedings
04.12.2014Minutes of the oral proceedings despatched
Fees paidRenewal fee
30.06.1999Renewal fee patent year 03
27.06.2000Renewal fee patent year 04
27.06.2001Renewal fee patent year 05
26.06.2002Renewal fee patent year 06
25.06.2003Renewal fee patent year 07
27.05.2004Renewal fee patent year 08
31.05.2005Renewal fee patent year 09
31.03.2006Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCH27.09.2006
FI27.09.2006
LI27.09.2006
DK27.12.2006
SE27.12.2006
LU09.06.2007
MC30.06.2007
[2015/33]
Former [2010/05]FI27.09.2006
DK27.12.2006
SE27.12.2006
LU09.06.2007
MC30.06.2007
Former [2008/12]FI27.09.2006
DK27.12.2006
SE27.12.2006
MC30.06.2007
Former [2008/07]FI27.09.2006
DK27.12.2006
SE27.12.2006
Former [2007/17]FI27.09.2006
SE27.12.2006
Documents cited:Search[DA]EP0094611  (CEDARS SINAI MEDICAL CENTER [US]) [DA] 1-9* the whole document *;
 [DA]EP0567448  (IMMUNO AG [AT]) [DA] 1-9 * the whole document *;
 [DA]WO9417834  (OCTAPHARMA AG [CH], et al) [DA] 1-9 * the whole document *;
 [X]  - ARRIGHI S ET AL, ""In vitro" and in animal model studies on a double virus -inactivated factor VII concentrate.", THROMBOSIS AND HAEMOSTASIS 74 (3). 1995. 868-873, XP002040293 [X] 1-9 * the whole document *
 [X]  - ELODI S ET AL, "Double virus inactivated F VIII concentrate: Virus validation and clinical efficacy of Haemoctin (Biotest F VIII SDH).", 39TH ANNUAL MEETING OF THE SOCIETY FOR THROMBOSIS AND HEMOSTASIS RESEARCH, BERLIN, GERMANY, FEBRUARY 15-18, 1995. ANNALS OF HEMATOLOGY 70 (SUPPL. 1). 1995. A35, XP002040294 [X] 1-9 * the whole document *
 [X]  - KOTITSCHKE, R. ET AL, "Double virus -inactivated factor VIII concentrate. Virus inactivation and validation of FVIII SDH", HAEMOSTASEOLOGIE (STUTTGART) (1994), 14(2), 100-3, (1994), XP002040295 [X] 1-9 * the whole document *
 [X]  - DICHTELMUELLER H ET AL, "Improvement of virus safety of a S-D-treated factor VIII concentrate by additional dry heat treatment at 100 degrees C.", BIOLOGICALS 24 (2). 1996. 125-130, XP002040296 [X] 1-9 * the whole document *

DOI:   http://dx.doi.org/10.1006/biol.1996.0016
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.